Syndax Pharmaceuticals reported strong Q3 2026 results with total revenue of $83.3 million, up 82% year-over-year, driven by a 90% increase in Revuforj net revenue to $60.7 million and a 47% rise in Niktimvo revenue to $67.4 million. The company highlighted growth in new patients and post-transplant therapy for Revuforj, positioning it as a leader in acute leukemia treatment. Syndax anticipates new clinical data releases in Q4 2026 and plans to advance its pipeline with new trials and drug candidates. Despite a net loss of $49.4 million, the company expects to reach profitability with its current cash and revenue streams.
Syndax Pharmaceuticals' Q3 2026 financial results provide context for health sector performance. For readers following health stocks, here is Pluang's market snapshot as of Nov 03, 2026 04:11 WIB: out of 150 priced US health-sector stocks, 48 rose and 100 fell. Notable movers include ABCL at USD 11.16 with a 9.05% decline and HIMS at USD 25.22 with 100% buy order activity on Pluang.
The Federal Home Loan Bank of Atlanta announced the election of three new member directors and the re-election of one independent director to its board for 2026. Suzanne DeFerie was named Chair and Kathy McKinney Vice Chair for 2027, ensuring experie...
Exosens disclosed its monthly update on the total number of shares and voting rights in its share capital as of October 31, 2026. The company has 50,936,749 shares outstanding, with 59,162,039 exercisable voting rights after deducting treasury shares...
Exosens has released its monthly update on the total number of shares and voting rights composing its capital as of October 31, 2026. The company reports 50,936,749 total shares and 59,425,768 theoretical voting rights, with 59,162,039 exercisable vo...
Cabot Corporation announced Q4 2026 diluted EPS of $1.25 and adjusted EPS of $1.61, with full-year diluted EPS at $4.02 and adjusted EPS at $6.42. The company reported strong segment EBITs, including $235 million from Performance Chemicals and $379 m...
Midland States Bancorp, Inc. announced a quarterly cash dividend of $0.33 per common share payable on November 20, 2026, to shareholders of record by November 13, 2026. Additionally, a cash dividend of $0.4844 per share was declared for its 7.75% Fix...
